you are viewing a single comment's thread
view the rest of the comments
[–] 4 points 5 months ago (3 children)

They were also using who-knows-what LLMs in a biotech context when we have specific regulations against using general use/commercially-available LLMs. We have rules against that for IP and HIPAA reasons. I’m genuinely baffled at how they didn’t get into Big Trouble for that.

  • source
  • parent
  • hideshow 3 child comments
  • [–] 1 point 5 months ago* (2 children)

    The landscape has shifted dramatically with the promise of big profits from higher productivity / labour cost reduction. Corpos used to be pretty strict with policies against putting proprietary code anywhere external. Now it's all like - yeah shove it in all these third parties' mouths, including sometimes competitors, it'll be part of your perf review. It's crazy. I don't think any of this is going back to the previous posture. The profit growth promise is too great.

  • source
  • parent
  • hideshow 2 child comments
  • [–] 2 points 5 months ago (1 child)

    Hey, if they want to give me a deeply stupid metric to achieve and tie it to comp - like, oh I don’t know, SLOC, or token usage - I am perfectly happy to game that system. And I have done in the past.

  • source
  • parent
  • hideshow 1 child comment
  • [–] 1 point 5 months ago*

    I think I'll have to start that soon. Apparently teaching and leading a bunch of juniors to deliver better than their pay grade isn't as valuable. I guess they think they can get rid of the juniors and have me do the same with cuckoding.

  • source
  • parent